Company Profile

Based in USA, Polymed Therapeutics has been at the forefront in the manufacture of APIs and Chemicals, with state-of-the-art and regulatory approved cGMP facilities and R&D laboratories in China.

For the past decade our API division has been a leader in the supply of pharmaceutical grade yet low cost specialty active ingredients and intermediates, for the global market. Our product portfolio has since expanded from Paclitaxel to more oncology APIs, Vitamin D analogues, plus other categories.

Our Fine Chemicals division specializes in Custom Synthesis, and serves the global markets of Pharmaceutical and Specialty Chemicals. Our team of scientists is expert in the whole range of manufacture - from R&D, pilot scale, to industrial scale. Being flexible and fast, our plants achieve extremely complex or simple synthesis, for large or small demands.

Polymed is financially stable, technologically proficient and dedicated to providing the most excellent products and services at competitive costs, to be the optimal strategic supplier to global customers.